The primary aim of ReSolve is to replace the hazardous solvents toluene and N-methyl-2-pyrrolidone (NMP) with safe alternatives derived from non-food carbohydrates. Starting from promising bio-based platform molecules, an effective combination of computational modelling, high-throughput toxicity testing and evaluation of application performance will be used to design bespoke bio-based solvents.
The project runs under the umbrella of the Bio-Based Industries Joint Undertaking (BBI JU) which is a public-private partnership between the European Commission and the Bio-based Industries Consortium. The ReSolve project consortium consists of 11 European companies. The project will run 3 years from June 2016- May 2020 with a total investment of 4.4 million euro.
The impact of this research is relevant to thousands of downstream businesses and consumers that are dependent on solvents. Above all, it will positively affect the health and safety of the millions of European citizens who are routinely exposed to solvents as part of their job.
In this project, the nova-Institute is responsible for the general outreach and dissemination activities within the project and will concentrate on determining the ecological, as well as the social and socio-economic impact of ReSolve’s processes and products. Moreover, the nova-Institute will also identify possible applications and market stakeholders via market analysis.
ReSolve receives funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovative programme under grant agreement No. 745450.
Dr. Ángel Puente